Anonymous Biopharma Pioneer

This biopharmaceutical company's Process Development division had accumulated over two million paper batch records across 15 years of scaling investigational therapeutics from R&D to clinical trial batches. The paper-based workflow created serious data integrity risks: transcription errors, missed signatures, and out-of-order production steps were inherent to manual processing. Records stored in a dedicated physical room were difficult to search, compare, or analyze. With more than a dozen therapeutics in active clinical development, the inability to access real-time data and verify quality during production — rather than after — represented both a compliance liability and a constraint on throughput.

After a competitive evaluation, the Process Development division selected FactoryTalk® PharmaSuite®, Rockwell Automation's Manufacturing Execution System (MES) built specifically for life sciences. This marked the first-ever PharmaSuite deployment in a Process Development capacity — a pioneering implementation within the industry. The rollout covered 10 complex recipes and system extensions, completed in 2023. Rockwell Automation's strategic account team and India-based configuration specialists worked closely with both the customer's business and IT teams throughout implementation, ensuring the MES was configured to match existing production processes. The close collaboration model — where business teams owned the configuration process from the start — was central to the deployment strategy, laying groundwork for future integration with GMP manufacturing, ERP, and data management platforms.

The PharmaSuite implementation delivered measurable operational gains across cycle time, throughput, and documentation:

• Batch cycle time reduced from 10 to 8 weeks — a 20% reduction per batch
• Two additional batches produced annually as a result of parallel processing capabilities
• 500 pages of paper saved per product campaign, totaling more than 3,000 pages per year
• Primary batch record reports that previously took several days to compile manually now generate in minutes at the press of a button
• Real-time quality verification replaced after-the-fact paper review, enabling in-batch corrections

Multiple users can now work within the system simultaneously, and the division has begun planning batch analytics and trending to improve production predictability.

• Start where risk and learning are manageable: Deploying MES in Process Development before GMP manufacturing allowed this company to build institutional knowledge and change management capacity with lower regulatory stakes.
• Business ownership of configuration drives adoption: When operations teams are involved from day one — not just IT — they understand the system and champion it through rollout.
• Paper elimination has compounding value: Reducing paper records isn't just a storage win; it unlocks searchable data, real-time analytics, and audit-ready reporting that paper simply cannot support.
• MES is a platform, not a point solution: Plan the integration roadmap (ERP, data management, GMP site) before go-live, even if execution is phased.
• Vendor proximity matters: Having responsive, on-call support during initial batches gave end users the confidence to operate the system without reverting to manual workarounds.